.jpg)
Key Features
- It is the first publication of its kind in the form of a 14th focused textbook of cardiology from India to the world.
- Over 300 contributors from India and abroad have contributed their prestigious chapters in this book, focusing on every aspect of obesity and lipid management including advances in management of obesity-inflicted morbidity and mortality such as CVD, CKD, DM, HF, and cardiometabolic modulation by GLP1RA such as Semaglutide and Tirzepatide and lipid management with statins, ezetimibe, bempedoic acid, PCSK9i, inclisiran apheresis, and gene therapy.
- The efficacy of drug therapy by biomarkers, echocardiography, and multimodality imaging is very well elucidated and has tremendous innovative and research potential of understanding advances in obesity and lipid management for the undergraduates, postgraduates, practicing cardiologists, endocrinologists, nephrologists, neurologists, critical care specialists, pulmonologists, pediatricians, pediatric surgeons, physicians, cardiovascular surgeons, imaging experts, nutritionists, etc.
- The book includes 23 sections and 172 chapters. The book is being dedicated to India and the world.
